4,216
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial

, , , , , , ORCID Icon, , & show all
Pages 5475-5486 | Received 10 Jun 2021, Accepted 14 Sep 2021, Published online: 29 Oct 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.